Back to Condition
Dystonia 6
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Dystonia 6

Dystonia 6 is a progressive neurological movement disorder characterized by involuntary muscle contractions, twisting, and tensing, primarily affecting the head and neck.

Overview

Dystonia 6 is one of many forms of dystonia, which is a group of conditions characterized by involuntary movements, twisting (torsion) and tensing of various muscles, and unusual positioning of affected body parts. Dystonia 6 can appear at any age from childhood through adulthood; the average age of onset is 18.

The signs and symptoms of dystonia 6 vary among affected individuals. The disorder usually first impacts muscles of the head and neck, causing problems with speaking (dysarthria) and eating (dysphagia). Eyelid twitching (blepharospasm) may also occur. Involvement of one or more limbs is common, and in some cases occurs before the head and neck problems. Dystonia 6 gradually gets worse, and it may eventually involve most of the body.

Frequency

The prevalence of dystonia 6 is unknown. Studies indicate that it likely accounts for between 1 and 3 percent of all cases of dystonia. For reasons that are unclear, the disorder appears to be slightly more prevalent in females than in males.

Causes

Dystonia 6 is caused by mutations in the THAP1 gene. This gene provides instructions for making a protein that is a transcription factor, which means that it attaches (binds) to specific regions of DNA and regulates the activity of other genes. Through this function, it is thought to help control several processes in the body, including the growth and division (proliferation) of endothelial cells, which line the inside surface of blood vessels and other circulatory system structures called lymphatic vessels. The THAP1 protein also plays a role in the self-destruction of cells that are no longer needed.

Studies indicate that most of the THAP1 gene mutations that cause dystonia 6 affect the stability of the THAP1 protein, reducing the amount of functional THAP1 protein available for DNA binding. Other mutations may impair the protein's ability to bind with the correct regions of DNA. Problems with DNA binding likely disrupt the proper regulation of gene activity, leading to the signs and symptoms of dystonia 6.

A particular THAP1 gene mutation is specific to a Mennonite population in the Midwestern United States in which dystonia 6 was first described. This mutation changes the DNA sequence in a region of the gene known as exon 2. Some researchers use the term DYT6 dystonia to refer to dystonia caused by this particular mutation, and the broader term THAP1 dystonia to refer to dystonia caused by any THAP1 gene mutation. In general, mutations affecting the region of the THAP1 protein that binds to DNA, including the mutation found in the Mennonite population, tend to result in more severe signs and symptoms than mutations affecting other regions of the protein.

Associated Genes

  • THAP1

Inheritance

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell can be sufficient to cause the disorder. Some people who inherit the altered gene never develop the condition, a situation known as reduced penetrance.

Other Names for This Condition

  • DYT6
  • DYT6 dystonia
  • Idiopathic torsion dystonia of mixed type
  • Primary dystonia, DYT6 type
  • THAP1 dystonia
  • Torsion dystonia 6

Frequently Asked Questions

Dystonia 6 can begin at any age, but often starts around 18. Initial signs commonly include involuntary muscle contractions, twisting, or tensing primarily affecting the head and neck. This can manifest as difficulty speaking (dysarthria), problems eating or swallowing (dysphagia), or eyelid twitching (blepharospasm). In some cases, limb involvement may occur before head and neck symptoms.
s Dystonia 6 progresses and can involve more of the body, management focuses on symptom relief and improving quality of life. This often includes medications to reduce muscle spasms, physical therapy to maintain flexibility and strength, and occupational therapy to adapt daily tasks. Speech therapy is crucial for dysarthria and dysphagia, helping with communication and safe swallowing techniques. Botulinum toxin injections may also be used for localized dystonia.
Dystonia 6 is caused by mutations in the THAP1 gene. It is typically inherited in an autosomal dominant pattern, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder. If an affected individual has children, each child has a 50% chance of inheriting the mutated gene and developing the condition. Genetic counseling can provide a more personalized risk assessment for families.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA